Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen people search for the best value Mounjaro in the UK, they're usually asking one question: am I paying a fair price for something safe and genuine? That's the right question. Mounjaro (tirzepatide) is a prescription-only medicine, so the value calculation is inseparable from the clinical infrastructure around it — the prescriber, the pharmacy, and the supply chain. A lower headline figure that cuts any of those corners isn't a better deal; it's a different product. Here's how to think through the decision clearly, and what legitimate providers actually differ on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Choosing where to get Mounjaro privately isn't like choosing where to buy a laptop. The medicine itself is identical across legitimate pharmacies, tirzepatide is tirzepatide, the KwikPen is the same pen, the dose is the same dose. What differs is everything wrapped around it: who assesses you, how thoroughly, how quickly, and what happens when you have a question at 8pm on a Sunday.
So the decision is less "which pharmacy sells it cheapest" and more "which service gives me the clinical oversight that makes this medicine safe for me to use." Those two questions have very different answers. On tirzepatide's clinical profile alone, Mounjaro's trial results (around 20–21% average body-weight reduction over 72 weeks in the SURMOUNT-1 trial, published in the New England Journal of Medicine) reflect patients who were properly assessed, titrated slowly, and supported throughout. Those results don't transfer automatically to anyone who just buys a pen.
The best value position, bluntly, is the one where the clinical and logistical package matches the seriousness of the medicine. That's not a vague platitude, it translates into specific, checkable things, covered below.
Since Eli Lilly raised Mounjaro's UK list price in September 2025, private market prices typically run from around £149 to £375 per four-week pen depending on strength and provider, as widely reported at the time. Within that range, the variation reflects a few genuine structural differences. Some providers charge separately for the consultation, the prescription, delivery, and any follow-up support; others bundle everything. A £149 quote that adds a £30 consultation fee and a £9.99 delivery charge is not cheaper than a £180 all-in quote. It's just presented differently.
Delivery logistics matter more than they sound. Mounjaro must be stored at 2–8°C, ideally in the fridge. A pen that sits in a warm courier depot over a bank-holiday weekend because the pharmacy chose the cheapest postal option is a pen whose cold chain you can't verify. Tracked, next-working-day refrigerated courier delivery is a functional clinical requirement, not a luxury add-on.
Our guide to buying Mounjaro in the UK covers what to ask any provider before placing an order. For detail on what an all-in price should realistically cover, the treatment overview at nume sets it out plainly. Aftercare support (a clinician you can actually contact when you have a concern) is another item that often goes unpriced and unprovided at the cheapest end of the market.
The MHRA has documented counterfeit tirzepatide pens entering the UK market, including an illicit manufacturing site raided in Northampton in October 2025. Fake pens have been found to contain insulin rather than tirzepatide, a substitution that can cause life-threatening hypoglycaemia. In that context, the question "is this a GPhC-registered pharmacy dispensing through the licensed UK supply chain?" is not bureaucratic box-ticking; it is the most important quality check you can perform.
The GPhC (General Pharmaceutical Council) maintains a public register of all registered pharmacies in the UK, searchable at pharmacyregulation.org/registers. Any online pharmacy unwilling or unable to provide a GPhC registration number is a red flag. So is a price dramatically below the market range, a social-media seller, or a checkout that dispenses the medicine without routing you through a clinical assessment first. The criteria for a legitimate Mounjaro supplier are worth reviewing before committing to any provider.
At nume, medicines are sourced through Eli Lilly's authorised UK supply chain and dispensed from our GPhC-registered pharmacy (registration: 9012878, verifiable at pharmacyregulation.org). That's not marketing; it's the baseline standard for a prescription medicine.
The NICE appraisal of tirzepatide (TA1026, published December 2024) confirms its clinical significance for weight management, which is part of why demand is high and prices reflect that. Within the private market, a genuinely competitive price is one that includes everything a responsible prescribing service must provide: identity verification, a clinical consultation reviewed by a real prescriber (not a questionnaire fired into a void), a valid prescription, genuine dispensing, cold-chain delivery, and a route to clinical support when questions come up between doses.
None of those elements are optional for a safely run service. If a price excludes them, it isn't competitive, it's incomplete. The cleanest route to getting Mounjaro safely is through a provider whose process you can trace from consultation to delivery. On practical questions like timing or technique, your prescriber and the Patient Information Leaflet are the right sources, not forum threads.
If the NHS route is relevant to you, eligibility criteria and waiting-list reality are worth understanding separately, see our full Mounjaro overview for the current NHS phasing. For those who don't meet NHS thresholds or prefer not to wait, the private route through a regulated provider is straightforward. Start by checking your eligibility through a free clinical consultation, it costs nothing, and a prescriber decides whether treatment is right for you before anything else happens.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.